Cargando…

Biomarker-guided withdrawal of inhaled corticosteroids in asthma patients with a non-T2 inflammatory phenotype – a randomized controlled trial study protocol

BACKGROUND: Non-T2 asthma is characterized by the absence of elevated type 2 inflammatory biomarkers such as blood-eosinophils, total and allergen-specific Immunoglobulin E and Fractional exhaled Nitric Oxide (FeNO). According to guidelines, inhaled corticosteroids (ICS) are the cornerstone of asthm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mosbech, Christiane Hammershaimb, Godtfredsen, Nina Skavlan, Ulrik, Charlotte Suppli, Westergaard, Christian Grabow
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552380/ https://www.ncbi.nlm.nih.gov/pubmed/37794472 http://dx.doi.org/10.1186/s12890-023-02679-y

Ejemplares similares

Comparison of Characteristics Between ICS-Treated COPD Patients and ICS-Treated COPD Patients with Concomitant Asthma: A Study in Primary Care
por: Savran, Osman, et al.
Publicado: (2020)

COPD patients prescribed inhaled corticosteroid in general practice: Based on disease characteristics according to guidelines?
por: Savran, Osman, et al.
Publicado: (2019)

COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
por: Savran, Osman, et al.
Publicado: (2021)

Pulmonary telerehabilitation vs. conventional pulmonary rehabilitation – a secondary responder analysis
por: Hansen, Henrik, et al.
Publicado: (2023)

Inhaled Corticosteroid Exposure and Risk of Cataract in Patients with Asthma and COPD: A Systematic Review and Meta-Analysis
por: Savran, Osman, et al.
Publicado: (2023)

Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma
por: Renzi-Lomholt, Martino, et al.
Publicado: (2022)

Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma
por: Jensen, Frodi Fridason, et al.
Publicado: (2021)

Determining Persistence with an Inhaled Corticosteroid in Asthma: Assessment Using an Objective Measurement vs the Self-Reported Foster Score
por: Hedegaard, Britt Overgaard, et al.
Publicado: (2022)

Withdrawal of Inhaled Corticosteroids in Patients with COPD – A Prospective Observational Study
por: Nielsen, Anne Orholm, et al.
Publicado: (2021)

Safety of bronchodilators and corticosteroids for asthma during pregnancy: what we know and what we need to do better
por: Gregersen, Thorbjørn Lomholt, et al.
Publicado: (2013)

Inflammatory phenotypes underlying uncontrolled childhood asthma despite inhaled corticosteroid treatment: rationale and design of the PACMAN2 study
por: Vijverberg, Susanne JH, et al.
Publicado: (2013)

Inhaled Corticosteroid Therapy in Bronchiectasis is Associated with All-Cause Mortality: A Prospective Cohort Study
por: Håkansson, Kjell E J, et al.
Publicado: (2021)

Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
por: Avdeev, Sergey, et al.
Publicado: (2019)

Relationship between early life asthma and chronic airway disease in adult life – in search for disease trajectories over the life span- the RELATE study based on the Kongsberg cohort
por: Savran, Osman, et al.
Publicado: (2023)

Inhaled Corticosteroids and Adult Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2019)

Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study
por: Damkjær, Mathias, et al.
Publicado: (2021)

Beta-Blockers in High-Risk Outpatients with Chronic Obstructive Pulmonary Disease are Associated with All-Cause Mortality – The STATUETTE Cohort Study
por: Damkjær, Mathias, et al.
Publicado: (2021)

The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma – a retrospective cohort study
por: Håkansson, K. E. J., et al.
Publicado: (2019)

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?
por: Maes, Tania, et al.
Publicado: (2020)

Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal
por: Yawn, Barbara P, et al.
Publicado: (2016)

One More Time: The Impact of Inhaled Corticosteroid Withdrawal on IMPACT
por: Han, MeiLan K., et al.
Publicado: (2020)

Oral prednisolone for 4 days does not increase exercise tolerance in men with COPD
por: Karlsson, SL, et al.
Publicado: (2017)

Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
por: Kim, Min-Hye, et al.
Publicado: (2019)

Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
por: Toogood, John H
Publicado: (2005)

Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice
por: Cataldo, Didier, et al.
Publicado: (2018)

Pragmatic trial on inhaled corticosteroid withdrawal in patients with COPD in general practice
por: van den Bemt, Lisette, et al.
Publicado: (2020)

Interorganisational Integration: Healthcare Professionals’ Perspectives on Barriers and Facilitators within the Danish Healthcare System
por: Lyngsø, Anne Marie, et al.
Publicado: (2016)

Abrupt withdrawal of inhaled corticosteroids does not result in spirometric deterioration in chronic obstructive pulmonary disease: Effect of phenotyping?
por: Al-Kassimi, Feisal A., et al.
Publicado: (2012)

Inhaled corticosteroids in childhood asthma: the story continues
por: van Aalderen, Wim M. C., et al.
Publicado: (2010)

Extrafine inhaled corticosteroid therapy in the control of asthma
por: Ivancsó, István, et al.
Publicado: (2013)

The use of inhaled corticosteroids in pediatric asthma: update
por: Hossny, Elham, et al.
Publicado: (2016)

Effect of inhaled corticosteroids on systemic inflammation in asthma
por: Karthikeyan, Ramaraju, et al.
Publicado: (2014)

Asthma progression and mortality: the role of inhaled corticosteroids
por: O'Byrne, Paul, et al.
Publicado: (2019)

Inhaled corticosteroids: not just for asthma, but for COVID-19?
por: Liew, Felicity, et al.
Publicado: (2022)

Inhaled Corticosteroids Is Not Associated with the Risk of Pneumonia in Asthma
por: Lee, Ye Jin, et al.
Publicado: (2023)

Beta-blockers: friend or foe in asthma?
por: Arboe, Bente, et al.
Publicado: (2013)

“Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD
por: Vogelmeier, Claus, et al.
Publicado: (2017)

Inhaled Corticosteroid Withdrawal in Chronic Obstructive Pulmonary Disease: Can IMPACT Help?
por: Suissa, Samy
Publicado: (2020)

The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
por: Wang, Cheng-Yi, et al.
Publicado: (2021)

A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
por: Patel, Smit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v0armb7qn8uvtos8jlnj7o8b62